Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients
Timothy R. Aksamit(Mayo Clinic), Beth Shoshanna Zha(University of California, San Francisco), Kevin Winthrop(Oregon Health & Science University), Doreen Addrizzo‐Harris(Unknown), Mark L. Metersky(University of Connecticut), Gregory Tino(University of Pennsylvania), Diego J. Maselli(South Texas Veterans Health Care System), Sarah Chalmers(Mayo Clinic), Nicholas Locantore(Research Triangle Park Foundation), Alan R. Barker(University of Portland), Ruth Tal‐Singer, Angela DiMango(Columbia University), Bruce E. Miller, N. Lapinel(Northwell Health), David Fraulino(University of Connecticut), Amanda E. Brunton(COPD Foundation), Edward T. Naureckas(University of Chicago), Radmila Choate(University of Kentucky), George M. Solomon(University of Alabama), Marcos I. Restrepo(South Texas Veterans Health Care System), Nathan C. Dean(Royal Marsden Hospital), Ashwin Basavaraj(New York University), Andreas Schmid(Justus-Liebig-Universität Gießen), Pamela J. McShane(National Heart Lung and Blood Institute), Gloria Rhyne(Portland State University), Elly Prusinowski(University of Chicago), Megan Behrman(University of Kansas Medical Center), Heather E. Warren(University of Connecticut), C. Richards(Massachusetts General Hospital), Sumith Abraham Varghese(University of Connecticut), Anne E. O’Donnell(Georgetown University), Juzar Ali(Louisiana State University Health Sciences Center New Orleans), Byron Thomashow(Columbia University), K. Tsui(University of Chicago), Kenneth N. Olivier(University of North Carolina at Chapel Hill), Margaret M. Johnson(Jacksonville College)
Cited by 36
Related Papers
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|2010|3k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
|CHEST Journal|2006|1.2k
Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery
|CHEST Journal|2013|901
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
|European Respiratory Journal|2020|876